The U.S. Food and Drug Administration (FDA) has granted GW Pharmaceuticals Plc's experimental cannabis-derived epilepsy drug "orphan" status for a third group of patients affected by a rare form of the disease.

GW said on Thursday that its drug, Epidiolex, had been granted the status for the treatment of tuberous sclerosis complex (TSC), a rare genetic disorder that causes epilepsy in about 80 percent to 90 percent of the patients afflicted with it.

TSC is the third orphan indication that GW is targeting within its Epidiolex clinical development program.

Orphan status is granted to drugs aimed at treating rare diseases, giving the developer incentives such as a seven-year marketing exclusivity in the United States.

Click here to read the rest of the article

Reuters ~

Recent News Articles

Monday March 25

Greater Boston's First Pot Shop Opening Weekend Goes 'According To Plan' - Cannabis News

in Cannabis News

by Bruce Kennedy - Editor in Chief

Brookline can now be added to the short list of Massachusetts cities and towns where…

1281 hits

Monday March 25

CVS to sell CBD products in 800 stores in 8 states - Cannabis News

in Finance

by Bruce Kennedy - Editor in Chief

CBD-infused sprays, roll-ons, creams and salves will be offered as an 'alternative source of relief'.

1163 hits

Monday March 25

Nearly Half of Anxiety Patients Find Medical Marijuana More Effective Than Pills - Cannabis News

in Medical News

by Bruce Kennedy - Editor in Chief

A new study shows that people suffering from anxiety may be able to successfully transition…

1158 hits

Monday March 25

Utah is looking for software to run its medical cannabis program - Cannabis News

in Hi-Tech

by Bruce Kennedy - Editor in Chief

The state has started its search for multimillion-dollar software that will form the spine of…

1104 hits

Tuesday March 26

Hemp About To Be Removed From Texas’ Controlled Substances List - Cannabis News

in Law & Crime

by Bruce Kennedy - Editor in Chief

The state of Texas is taking a big step toward legitimizing the use of CBD…

828 hits